nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—CHRNG—tongue—Parkinson's disease	0.0309	0.115	CbGeAlD
Decamethonium—CHRNA1—tongue—Parkinson's disease	0.0205	0.0765	CbGeAlD
Decamethonium—HRH3—hindbrain—Parkinson's disease	0.0194	0.0725	CbGeAlD
Decamethonium—HRH3—brainstem—Parkinson's disease	0.0111	0.0416	CbGeAlD
Decamethonium—HRH3—forebrain—Parkinson's disease	0.0107	0.0401	CbGeAlD
Decamethonium—CHRNG—medulla oblongata—Parkinson's disease	0.00947	0.0354	CbGeAlD
Decamethonium—CHRND—cardiovascular system—Parkinson's disease	0.00879	0.0328	CbGeAlD
Decamethonium—CHRNG—midbrain—Parkinson's disease	0.00866	0.0323	CbGeAlD
Decamethonium—CHRNG—head—Parkinson's disease	0.00751	0.028	CbGeAlD
Decamethonium—CHRNA2—forebrain—Parkinson's disease	0.0072	0.0269	CbGeAlD
Decamethonium—HRH3—head—Parkinson's disease	0.00615	0.023	CbGeAlD
Decamethonium—HRH3—nervous system—Parkinson's disease	0.00583	0.0218	CbGeAlD
Decamethonium—HRH3—central nervous system—Parkinson's disease	0.00561	0.021	CbGeAlD
Decamethonium—HRH3—cerebellum—Parkinson's disease	0.00548	0.0205	CbGeAlD
Decamethonium—CHRNA1—head—Parkinson's disease	0.00497	0.0186	CbGeAlD
Decamethonium—CHRNB1—medulla oblongata—Parkinson's disease	0.00484	0.0181	CbGeAlD
Decamethonium—HRH3—brain—Parkinson's disease	0.00445	0.0166	CbGeAlD
Decamethonium—CHRNB1—midbrain—Parkinson's disease	0.00442	0.0165	CbGeAlD
Decamethonium—CHRNB1—spinal cord—Parkinson's disease	0.00432	0.0161	CbGeAlD
Decamethonium—CHRM2—forebrain—Parkinson's disease	0.00429	0.016	CbGeAlD
Decamethonium—ACHE—medulla oblongata—Parkinson's disease	0.0042	0.0157	CbGeAlD
Decamethonium—CHRNA2—head—Parkinson's disease	0.00412	0.0154	CbGeAlD
Decamethonium—CHRNA2—nervous system—Parkinson's disease	0.00391	0.0146	CbGeAlD
Decamethonium—CHRNB1—head—Parkinson's disease	0.00384	0.0143	CbGeAlD
Decamethonium—ACHE—midbrain—Parkinson's disease	0.00384	0.0143	CbGeAlD
Decamethonium—CHRNA2—central nervous system—Parkinson's disease	0.00376	0.0141	CbGeAlD
Decamethonium—ACHE—spinal cord—Parkinson's disease	0.00374	0.014	CbGeAlD
Decamethonium—CHRNA2—cerebellum—Parkinson's disease	0.00368	0.0137	CbGeAlD
Decamethonium—CHRM2—cardiovascular system—Parkinson's disease	0.00363	0.0136	CbGeAlD
Decamethonium—CHRNA1—brain—Parkinson's disease	0.0036	0.0135	CbGeAlD
Decamethonium—CHRNB1—cerebellum—Parkinson's disease	0.00342	0.0128	CbGeAlD
Decamethonium—CHRNA2—brain—Parkinson's disease	0.00299	0.0112	CbGeAlD
Decamethonium—ACHE—cerebellum—Parkinson's disease	0.00297	0.0111	CbGeAlD
Decamethonium—BCHE—brainstem—Parkinson's disease	0.00296	0.0111	CbGeAlD
Decamethonium—BCHE—forebrain—Parkinson's disease	0.00286	0.0107	CbGeAlD
Decamethonium—CHRNB1—brain—Parkinson's disease	0.00278	0.0104	CbGeAlD
Decamethonium—CHRM2—head—Parkinson's disease	0.00246	0.00919	CbGeAlD
Decamethonium—BCHE—cardiovascular system—Parkinson's disease	0.00241	0.00902	CbGeAlD
Decamethonium—ACHE—brain—Parkinson's disease	0.00241	0.00901	CbGeAlD
Decamethonium—CHRM2—nervous system—Parkinson's disease	0.00233	0.00871	CbGeAlD
Decamethonium—CHRM2—central nervous system—Parkinson's disease	0.00224	0.00839	CbGeAlD
Decamethonium—BCHE—medulla oblongata—Parkinson's disease	0.00206	0.00771	CbGeAlD
Decamethonium—BCHE—midbrain—Parkinson's disease	0.00189	0.00704	CbGeAlD
Decamethonium—BCHE—spinal cord—Parkinson's disease	0.00184	0.00687	CbGeAlD
Decamethonium—CHRM2—brain—Parkinson's disease	0.00178	0.00666	CbGeAlD
Decamethonium—BCHE—head—Parkinson's disease	0.00163	0.00611	CbGeAlD
Decamethonium—BCHE—nervous system—Parkinson's disease	0.00155	0.00579	CbGeAlD
Decamethonium—BCHE—central nervous system—Parkinson's disease	0.00149	0.00558	CbGeAlD
Decamethonium—BCHE—cerebellum—Parkinson's disease	0.00146	0.00545	CbGeAlD
Decamethonium—BCHE—brain—Parkinson's disease	0.00118	0.00443	CbGeAlD
Decamethonium—BCHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000316	0.000431	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000314	0.000429	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000311	0.000424	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GRK5—Parkinson's disease	0.000308	0.00042	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—RPL6—Parkinson's disease	0.000306	0.000418	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000306	0.000418	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000301	0.000411	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—DLG4—Parkinson's disease	0.000297	0.000406	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.000296	0.000404	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000295	0.000403	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000293	0.0004	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000291	0.000397	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—GRIN2B—Parkinson's disease	0.000291	0.000397	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00029	0.000397	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—SLC6A3—Parkinson's disease	0.000286	0.000391	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000286	0.000391	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000283	0.000386	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.00028	0.000383	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000278	0.000379	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000277	0.000378	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GRM4—Parkinson's disease	0.000276	0.000377	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—TAC1—Parkinson's disease	0.000274	0.000374	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—RPL6—Parkinson's disease	0.000273	0.000373	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—COMT—Parkinson's disease	0.000273	0.000373	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000272	0.000371	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—MAOA—Parkinson's disease	0.000271	0.00037	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00027	0.000368	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—DRD1—Parkinson's disease	0.000268	0.000366	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000267	0.000365	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000266	0.000364	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000266	0.000363	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.000266	0.000363	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PENK—Parkinson's disease	0.000262	0.000357	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAG—Parkinson's disease	0.000262	0.000357	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ND3—Parkinson's disease	0.000261	0.000356	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MCCC1—Parkinson's disease	0.000261	0.000356	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00026	0.000356	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—DRD3—Parkinson's disease	0.00026	0.000355	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000259	0.000354	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000259	0.000353	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000259	0.000353	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.000257	0.00035	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000252	0.000344	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000251	0.000343	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000247	0.000337	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000246	0.000336	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000246	0.000336	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TALDO1—Parkinson's disease	0.000245	0.000335	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—OMD—Parkinson's disease	0.000245	0.000335	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—COMT—Parkinson's disease	0.000243	0.000332	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000243	0.000331	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—MAOA—Parkinson's disease	0.000242	0.00033	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PDYN—Parkinson's disease	0.000239	0.000327	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000239	0.000326	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.000238	0.000326	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.000237	0.000324	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HTR7—Parkinson's disease	0.000235	0.000321	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—DRD2—Parkinson's disease	0.000235	0.000321	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ND3—Parkinson's disease	0.000233	0.000317	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MCCC1—Parkinson's disease	0.000233	0.000317	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NDUFB11—Parkinson's disease	0.000232	0.000317	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—RPL14—Parkinson's disease	0.000232	0.000317	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.000232	0.000317	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000231	0.000316	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000228	0.000312	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000228	0.000312	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000228	0.000311	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GFAP—Parkinson's disease	0.000225	0.000307	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000223	0.000305	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000223	0.000305	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000223	0.000305	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GRM5—Parkinson's disease	0.000222	0.000304	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GCH1—Parkinson's disease	0.000222	0.000303	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TALDO1—Parkinson's disease	0.000219	0.000299	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—OMD—Parkinson's disease	0.000219	0.000299	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—RPS8—Parkinson's disease	0.000217	0.000296	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000216	0.000295	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NDUFB11—Parkinson's disease	0.000207	0.000283	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000207	0.000283	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.000207	0.000283	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	0.000207	0.000283	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000204	0.000279	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000203	0.000277	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.0002	0.000273	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GCH1—Parkinson's disease	0.000198	0.00027	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—FBP1—Parkinson's disease	0.000198	0.00027	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GBA—Parkinson's disease	0.000198	0.00027	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—DBH—Parkinson's disease	0.000198	0.00027	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000195	0.000267	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000195	0.000267	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—FGF20—Parkinson's disease	0.000195	0.000266	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	0.000193	0.000264	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000189	0.000258	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—EDN1—Parkinson's disease	0.000188	0.000257	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000186	0.000255	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000181	0.000247	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000178	0.000243	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000177	0.000242	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—FBP1—Parkinson's disease	0.000176	0.000241	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—DBH—Parkinson's disease	0.000176	0.000241	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GBA—Parkinson's disease	0.000176	0.000241	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000176	0.00024	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—INSR—Parkinson's disease	0.000175	0.000238	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000173	0.000237	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.00017	0.000232	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000169	0.000231	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000167	0.000228	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—FGB—Parkinson's disease	0.000165	0.000225	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000165	0.000225	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000165	0.000225	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HTR1A—Parkinson's disease	0.000164	0.000224	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000163	0.000222	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TAC1—Parkinson's disease	0.000162	0.000221	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00016	0.000218	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.000159	0.000217	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.000159	0.000216	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—DRD1—Parkinson's disease	0.000158	0.000216	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000156	0.000214	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—DRD3—Parkinson's disease	0.000153	0.00021	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000152	0.000207	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000149	0.000203	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000149	0.000203	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—DDC—Parkinson's disease	0.000145	0.000198	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000145	0.000198	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.000144	0.000197	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000143	0.000196	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000141	0.000193	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—DRD2—Parkinson's disease	0.000139	0.00019	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HTR7—Parkinson's disease	0.000139	0.00019	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTA4—Parkinson's disease	0.000137	0.000187	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000137	0.000187	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000135	0.000185	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000135	0.000184	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.000132	0.00018	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.000132	0.00018	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.000132	0.00018	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—DDC—Parkinson's disease	0.000129	0.000177	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	0.000129	0.000176	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000129	0.000176	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PLA2G6—Parkinson's disease	0.000123	0.000168	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.000122	0.000167	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTA4—Parkinson's disease	0.000122	0.000167	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MAOB—Parkinson's disease	0.000122	0.000167	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000121	0.000165	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000121	0.000165	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000119	0.000163	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF2—Parkinson's disease	0.000116	0.000159	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000116	0.000159	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	0.000115	0.000157	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000115	0.000156	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF1R—Parkinson's disease	0.000112	0.000154	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EDN1—Parkinson's disease	0.000111	0.000152	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PLA2G6—Parkinson's disease	0.00011	0.00015	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MAOB—Parkinson's disease	0.000109	0.000149	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000105	0.000144	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000104	0.000142	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000104	0.000142	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000104	0.000141	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NGF—Parkinson's disease	0.000102	0.000139	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.0001	0.000137	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.94e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	9.79e-05	0.000134	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HTR2A—Parkinson's disease	9.72e-05	0.000133	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	9.6e-05	0.000131	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	9.3e-05	0.000127	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP2D6—Parkinson's disease	9.07e-05	0.000124	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—APOE—Parkinson's disease	9.04e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	9.03e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	8.97e-05	0.000122	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CTGF—Parkinson's disease	8.9e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	8.89e-05	0.000121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	8.72e-05	0.000119	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.68e-05	0.000119	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—INS—Parkinson's disease	8.57e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAG—Parkinson's disease	8.5e-05	0.000116	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PENK—Parkinson's disease	8.5e-05	0.000116	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	8.45e-05	0.000115	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	8.41e-05	0.000115	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	8.41e-05	0.000115	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP2E1—Parkinson's disease	8.29e-05	0.000113	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	8.29e-05	0.000113	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NQO1—Parkinson's disease	8.2e-05	0.000112	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP2D6—Parkinson's disease	8.09e-05	0.00011	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TH—Parkinson's disease	8.08e-05	0.00011	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CTGF—Parkinson's disease	7.94e-05	0.000108	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.89e-05	0.000108	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	7.78e-05	0.000106	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYCS—Parkinson's disease	7.76e-05	0.000106	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—INS—Parkinson's disease	7.72e-05	0.000105	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—INS—Parkinson's disease	7.65e-05	0.000104	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	7.64e-05	0.000104	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	7.64e-05	0.000104	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP2E1—Parkinson's disease	7.4e-05	0.000101	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NQO1—Parkinson's disease	7.32e-05	9.99e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	7.31e-05	9.98e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	7.23e-05	9.87e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TH—Parkinson's disease	7.21e-05	9.85e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYCS—Parkinson's disease	6.92e-05	9.45e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—COMT—Parkinson's disease	6.87e-05	9.39e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTP1—Parkinson's disease	6.84e-05	9.34e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MAOA—Parkinson's disease	6.82e-05	9.32e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—HMOX1—Parkinson's disease	6.75e-05	9.21e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	6.73e-05	9.2e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—Parkinson's disease	6.48e-05	8.84e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	6.34e-05	8.66e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTM1—Parkinson's disease	6.29e-05	8.58e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	6.15e-05	8.39e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—COMT—Parkinson's disease	6.13e-05	8.37e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	6.12e-05	8.35e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTP1—Parkinson's disease	6.1e-05	8.33e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MAOA—Parkinson's disease	6.09e-05	8.31e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GPX1—Parkinson's disease	6.02e-05	8.22e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—HMOX1—Parkinson's disease	6.02e-05	8.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.89e-05	8.04e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—Parkinson's disease	5.78e-05	7.89e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—Parkinson's disease	5.75e-05	7.85e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—Parkinson's disease	5.71e-05	7.8e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—INSR—Parkinson's disease	5.67e-05	7.75e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTM1—Parkinson's disease	5.61e-05	7.66e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MTHFR—Parkinson's disease	5.56e-05	7.59e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GPX1—Parkinson's disease	5.37e-05	7.33e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGB—Parkinson's disease	5.36e-05	7.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	5.35e-05	7.3e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	5.33e-05	7.28e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK8—Parkinson's disease	5.28e-05	7.21e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	5.25e-05	7.17e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—APOE—Parkinson's disease	5.17e-05	7.06e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	5.15e-05	7.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	4.99e-05	6.81e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MTHFR—Parkinson's disease	4.96e-05	6.77e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	4.66e-05	6.36e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—APOE—Parkinson's disease	4.61e-05	6.3e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	4.51e-05	6.16e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	4.51e-05	6.16e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—INS—Parkinson's disease	4.42e-05	6.03e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—INS—Parkinson's disease	3.94e-05	5.38e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	3.78e-05	5.16e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	3.66e-05	4.99e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	3.61e-05	4.93e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—Parkinson's disease	3.37e-05	4.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NGF—Parkinson's disease	3.32e-05	4.53e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	3.16e-05	4.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.94e-05	4.01e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.51e-05	3.43e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.87e-05	2.55e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.86e-05	2.54e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.72e-05	2.35e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.1e-05	1.5e-05	CbGpPWpGaD
